Also, there was a decreasing trend of KILLIN expression levels in patients with breast cancer and thyroid cancer, those with breast cancer only, and those with thyroid cancer only relative to healthy controls ( Figure 2B ).
← all excerpts
Elevation of methylated DNA in KILLIN/PTEN in the plasma of patients with thyroid and/or breast cancer.
1
—
—